Our Story


Frontier Biotechnologies Inc.

Founded in 2013, Frontier Biotechnologies Inc. ("Frontier Biotech") is committed to drug discovery, clinical development, manufacturing, and commercialization of innovative medicines that improve patients’ health.

Frontier Biotech is a commercial-stage biopharmaceutical company headquartered in Nanjing, China with global vision and world-class competitiveness. It has been publicly listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange since 2020 (stock code “688221.SH”).

Hailed as one of the leading biotechnology companies in China in the field of innovative drug development for HIV and AIDS treatments, it is the leading unit of the AIDS project in development of new medicine in the national “Thirteenth Five-Year Plan”. Frontier Biotech has received numerous awards and accolades over the years. Aikening® IV infusion won the Science and Technology Award in Jiangsu Province.

Over a decade of commitment, Frontier Biotech has established a strong team with global vision and deep expertise, poised for international expansion. It has built a fully-integrated, state-of-the-art long-acting peptide drug innovation platform. In addition to the commercialization of Aikening®, a long-acting HIV fusion inhibitor, Frontier Biotech is advancing an array of clinical assets through its diversified R&D pipeline, with on-going clinical trials in China and the United States.

The company has established API and final drug product production capabilities and built state-of-the-art manufacturing plants in Nanjing, Sichuan and Shandong. These manufacturing sites comply with international pharmaceuticals manufacturing standards and are certified by US FDA, cGMP, EMA GMP and PICS.

Aikening® has received Marketing Authorization in China since 2018 and subsequent Marketing Authorizations were obtained in Ecuador, Cambodia, Malaysia, Azerbaijan and Kazakhstan.

Enterprise history
State-of-the-Art Manufacturing
  • Nanjing Site
  • Sichuan Site
  • Shandong

Develop Innovative Therapies to Better Human Lives